Cardiac amyloidosis, European green light for treatment with acoramidis
MILAN (ITALPRESS) – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for acoramidis, an orally administered selective small molecule that stabilizes transthyretin (TTR), in the European Union (EU). This […]
Cardiac amyloidosis, European green light for treatment with acoramidis Read More »